CEO of Pfizer partner BioNTech says coming winter will be hard but by April, 300 million immunization units should be ready, which will have an impact on the global pandemic.
If coronavirus vaccinations are rolled out widely, life could return to normal by next winter, one of the scientists behind the front-running coronavirus vaccine told British television on Sunday.
Ugur Sahin, the Turkish co-founder of the German firm BioNTech, told the BBCs The Andrew Marr Show that this winter will be hard, without any major impact from vaccinations.
Together with US giant Pfizer, BioNTech is developing the leading candidate in the worldwide chase for a vaccine. Israel has ordered millions of units of the vaccine, hoping that the first deliveries will arrive in the country by January.
Affected by the new coronary pneumonia epidemic, the Ammonium iron(II) sulfate hexahydrate ((NH4)2Fe(SO4)2 xH2O (x
Is boron amorphous or crystalline?Boron can be prepared in several crystalline and amorphous forms. The well-known forms of crystallization are α-rhombohedral (α-R), β-rhombohedral (β-R) and β-tetragonal (β-T). In spec…
What is copper oxide?Copper oxide is an inorganic substance. Copper oxide chemical formula is CuO. It is a black oxide of copper. Slightly bisexual and slightly hygroscopic. Insoluble in water and ethanol, easily soluble in acid, thermally stable, de…
Expandable graphite or exfoliated graphite is made from the naturally occurring mineral graphite. The layered structure of graphite allows molecules to be inserted between the graphite layers. By adding acid, graphite sulfate can usually be converted…